$25, at the current # of shares, only gives MindMed about an $8 billion market cap. That is tiny for what will likely be the company that leads the sea change in mental health pharmaceuticals/treatment, as well as addiction management. $25 within 2 years sure ... but in 4-6 years I see a market cap of at least $40-$50 billion. This isn't a company with all their eggs in one basket.
Market Data 
Markets 
AI
